Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Tissue Engineers Steering Stem Cells to Produce Bones, Cartilage

22.08.2002


Placing These Cells in Injectable Hydrogel May Provide New Way to Repair Joints



Johns Hopkins University researchers have caused stem cells from adult goats to grow into tissue that resembles cartilage, a key step toward creating a minimally invasive procedure that may one day be used to repair injured knees, noses and other body parts.

In this method, doctors would inject a fluid filled with stem cells and nutrients into damaged tissue, then use light to harden the liquid into a stable gel. Although human testing remains years away, the researchers believe stem cells within the gel will multiply and form new bone or cartilage to replace the injured tissue.


Paving the way for this technique, the researchers have conducted lab experiments that turned stem cells within a gel into cartilage-like tissue. The team expects to begin testing the process on mice this fall, says Jennifer Elisseeff, assistant professor in the Department of Biomedical Engineering. Elisseeff is leading a multi-disciplinary tissue engineering team that includes a plastic surgeon, an orthopedic surgeon, a polymer chemist and graduate students, all affiliated with the Whitaker Biomedical Engineering Institute at Johns Hopkins.

The team’s goal is to develop a new way to deliver and control the behavior of adult stem cells to restore bone and cartilage that has been damaged by disease or injury or is impaired by a genetic defect. Restoration of cartilage – the tough but elastic tissue in noses, ears and joints – would be particularly helpful because, unlike skin, cartilage does not naturally regenerate. Routine use of this procedure in humans may be many years away, Elisseeff says, but the potential benefits could be significant. For one thing, if the lab results can be replicated in humans, patients would end up with living tissue rather than metal or plastic replacement parts. “If this technique ultimately works the way we believe it will, doctors will have a new and possibly more effective option for treating severe joint injuries,” Elisseeff says. “This procedure would also help people avoid invasive surgery.”

Like many new research projects, this work uses stem cells because they have the ability to renew themselves and also to develop into many types of tissue. Elisseeff’s lab is using adult multipotent cells, meaning they can be stimulated to produce different types of musculoskeletal tissue. Ethical debates surrounding stem cell research have focused on material removed from human embryos and fetuses, not the adult cells used in Elisseeff’s experiments. Adult cells offer another advantage: In theory, patients preparing for cartilage or bone repairs will be able to donate their own stem cells prior to the procedure, reducing the likelihood of infection and tissue rejection.

MIT’s Technology Review magazine recently recognized Elisseeff, 28, as one of the World’s Top 100 Young Innovators in technology and business. Her current project, funded by the Arthritis Foundation, builds on work she began as a graduate student in the Harvard University-MIT Division of Health Sciences and Technology. Elisseeff was lead researcher in developing a polymer fluid–laced with cartilage cells called chondrocytes – that can be injected under the skin. The liquid is then hardened by shining an ultraviolet light or visible laser through the skin. The solid material,called a hydrogel, forms a scaffold or framework upon which cells can reproduce and form new tissue.

“Photopolymerizing hydrogels are very useful because they only harden when light is applied,” Elisseeff says. “Also, primary chondrocytes – cartilage cells – can be encapsulated in these hydrogels and will form cartilage-like tissue. The cells thrive because hydrogels contain plenty of water, which is needed to carry nutrients to these cells and move waste products away from them. The hydrogels also have enough space to allow the new tissue to form.”

Now, in a new lab at Johns Hopkins, Elisseeff and her colleagues are placing stem cells in her hydrogels and coaxing them to produce cartilage and an early form of bone within the polymer framework. Recently, Christopher Williams, a plastic surgery fellow in the lab, has conducted experiments with stem cells derived from the bone marrow of adult goats. By surrounding these cells with a specific growth factor that helps direct cellular differentiation, Williams has prodded the stem cells into forming what lab tests indicate are osteoblasts (cells that develop into bone) or chondrocytes. The cartilage samples show the proper gene expression and a cartilage-specific extracellular matrix. Lab tests show that the bone precursor cells are producing calcium, a first step toward osteogenesis, the formation of bone.

“This means that in the lab we’ve already used adult stem cells to create tissue resembling cartilage by composition and morphology in the photopolymerizing hydrogel, and early tests indicate this technique may work with bones, too,” Elisseeff says. “Other researchers have formed cartilage and bone from stem cells in the laboratory. But by applying this to the injectable hydrogel, we think we’ve come up with a clinically practical way to deliver the cells to the site of an injury, where they can grow to replace injured bone or cartilage. Some difficulties still exist in smoothly joining new cells to the recipient’s own tissue, but we’re working on these problems.”

Elisseeff’s team is now fine-tuning the technique. The researchers are synthesizing a new hydrogel that should degrade harmlessly in the body after the new tissue develops. Also, the team is refining its cell growth methods to more closely mimic the normal development of cartilage and bone cells. Elisseeff and her colleagues have submitted some of their lab results to a peer-reviewed journal.

Phil Sneiderman | EurekAlert!

More articles from Health and Medicine:

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht On track to heal leukaemia
18.01.2017 | Universitätsspital Bern

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

New Study Will Help Find the Best Locations for Thermal Power Stations in Iceland

19.01.2017 | Earth Sciences

Not of Divided Mind

19.01.2017 | Life Sciences

Molecule flash mob

19.01.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>